Evidence map›Paper›PMID 33786155›Full record

ArticleInternational journal of clinical and experimental pathology2021

Primary hepatic mucosa-associated lymphoid tissue lymphoma: case report and literature review.

Zhengqi Fu, Lixia Wu, Jiaming Chen, Qichang Zheng, Ping Li, Li Zhang, Chuanming Zhu, Zhengshou Rao, Shaobo Hu

Open access · greenAbstract readCase Reports
In one paragraph

Article in International journal of clinical and experimental pathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Zhengqi FuDepartment of Pathology and Pathophysiology, School of Medicine, Jianghan University Wuhan 430056, Hubei, China.
Lixia WuDepartment of Pathology and Pathophysiology, School of Medicine, Jianghan University Wuhan 430056, Hubei, China.
Jiaming ChenDepartment of Pathology and Pathophysiology, School of Medicine, Jianghan University Wuhan 430056, Hubei, China.
Qichang ZhengDepartment of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan 430056, China.
Ping LiDepartment of General Surgery, The People's Hospital of Honghu City Honghu 430022, Hubei, China.
Li ZhangDepartment of General Surgery, The People's Hospital of Honghu City Honghu 430022, Hubei, China.
Chuanming ZhuDepartment of General Surgery, The People's Hospital of Honghu City Honghu 430022, Hubei, China.
Zhengshou RaoDepartment of General Surgery, The People's Hospital of Honghu City Honghu 430022, Hubei, China.
Shaobo HuDepartment of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan 430056, China.
Honghu People’s Hospital · CNJianghan University · CNFujian Medical University · CNWuhan Union Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe prevalence of primary hepatic mucosa-associated lymphoid tissue (MALT) lymphomas is extremely low. Here, we describe a case of this disease misdiagnosed as hepatocellular carcinoma (HCC) and review relevant literature to prevent future misdiagnoses. CASE PRESENTATION: a 58-year-old woman complained about abdominal pain for more than four months. About two months prior, she came to our hospital with elevated levels of HBV DNA and positive HBsAg and HBcAb. After two months of entecavir treatment, HBV DNA decreased to a normal level. She returned to the hospital with worsened abdominal pain for over a month. Magnetic resonance imaging and systemic positron emission tomography-computed tomography identified two nodes in the liver, and she was diagnosed with HCC. The patient then underwent a laparoscopic hepatectomy. Microscopic examination showed a diffuse infiltrate of small-to-medium-sized lymphocytes and lymphoepithelial lesions. Immunohistochemical staining showed that most of the lymphoid cells were strongly positive for CD20, CD79a, BCL2, IgM and weakly positive for IgD, while negative for CD3, CD10, BCL6, MUM1, CD43, CD5, cyclin D1, CD23, CD30, and PD1. The Ki-67 index of lymphoid cells was 5%. Further pathologic analysis confirmed the diagnosis of primary hepatic MALT lymphoma. The patient received antiviral treatment and recovered well with no sign of relapse for 17 months.

conclusionsPrimary hepatic MALT lymphoma is an uncommon disease that is difficult to diagnose and has no widely accepted treatment. Surgical resection is a good choice for both diagnosis and local therapy, and strict follow-up of the patient is essential.

Indexed as

hepatitis B virusliver hepatectomymisdiagnosisPrimary hepatic mucosa-associated lymphoid tissue lymphomaradiological imagetreatment modality

Identifiers

PMID33786155
PMCPMC7994143
OpenAlexW3145377235

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.